Coats Disease

Coats disease is an uncommon, non‑hereditary eye disorder in which the tiny blood vessels (capillaries) inside the retina become abnormally dilated, twisted, and leaky. These unhealthy vessels ooze fluid rich in fats (lipoproteins) and sometimes blood into the surrounding retinal tissue. As the leakage builds up, yellow‑white fatty deposits called “hard exudates” collect under and within the retina, causing it to swell and, in advanced cases, to detach from the back wall of the eye. The condition usually affects just one eye (about 75 % of patients) and is most often detected in boys during early childhood, although adults of any gender can develop a late‑onset form.

Unlike diabetic retinopathy, Coats disease does not stem from high blood sugar, and unlike retinoblastoma, it is not a cancer. It belongs to a group of disorders collectively known as idiopathic retinal telangiectasias—“idiopathic” meaning doctors still do not know the exact trigger, and “telangiectasia” describing the balloon‑like widening of small blood vessels. Over time the chronic leakage starves the retina of oxygen, stimulates harmful growth signals such as vascular endothelial growth factor (VEGF), and gradually impairs central and peripheral vision. If untreated, Coats disease can lead to severe and irreversible sight loss or even a blind, painful eye that may need removal. Early recognition and precise diagnosis are therefore critical.

---

Main Types of Coats Disease

Although every patient is unique, eye specialists usually group Coats disease into several overlapping patterns to predict progress and plan care.

1. Classic (Childhood‑Onset) Coats Disease
   This is the textbook presentation seen in children—typically boys aged three to ten. It starts near the far edges of the retina with a sprinkle of leaky, sausage‑shaped vessels and slowly moves toward the macula (the high‑definition center of sight).

2. Adult‑Onset (Late‑Onset) Coats Disease
   Adults in their forties to sixties can develop a milder, more localized leakage that tends to remain peripheral. Vision may stay normal for years, and treatment often focuses on sealing isolated telangiectatic spots with laser or freezing therapy.

3. Coats‑Like Retinopathy Associated with Systemic Conditions
   Some systemic disorders—such as facioscapulohumeral muscular dystrophy, incontinentia pigmenti, and certain hemoglobinopathies—can produce a retinal picture almost identical to Coats disease. Because management depends on the underlying illness, ophthalmologists label these cases “Coats‑like” rather than true idiopathic Coats disease.

4. Coats Plus (Cerebroretinal Microangiopathy with Calcifications and Cysts)
   A rare genetic syndrome caused by mutations in the CTC1 gene features retinal telangiectasia plus brain calcifications, fragile bones, and gastrointestinal bleeding. The eye findings mimic severe infantile Coats disease but demand genetic counseling and multi‑system care.

5. Staged Progression (Shields Classification)
   Even within one type, most specialists describe the disease in five progressive stages—from isolated telangiectasia without exudate (Stage 1) to total retinal detachment and painful eye (Stage 5). Knowing the stage helps predict outcomes and choose treatments such as laser, cryotherapy, anti‑VEGF injections, or surgery.

---

Causes and Contributing Factors

Researchers have not pinpointed one single cause, but several lines of evidence highlight a complex web of genetic, developmental, and environmental influences. Each factor below is explained in plain language so you can grasp how it might set the stage for retinal leakage.

1. Random Developmental Glitch in Retinal Vessels
   The most widely accepted theory holds that Coats disease starts with a sporadic error during the final months of fetal retinal vessel formation. A patch of capillaries never acquires the normal coating of support cells (pericytes) and smooth muscle, making them fragile and prone to ballooning.

2. Somatic (Non‑Inherited) NDP Gene Mutation
   A handful of studies have found mosaic mutations in the NDP gene—an important signal for retinal blood‑vessel maturation—in the abnormal tissue but not in the patient’s blood. This suggests a “one‑eye‑only” genetic typo that arises after conception, similar to a birthmark.

3. Excess Vascular Endothelial Growth Factor (VEGF)
   Leaky, poorly oxygenated retina pumps out VEGF, a potent chemical that triggers new vessel growth and further leakage. Elevated intraocular VEGF levels drive the vicious cycle of telangiectasia and exudation.

4. Loss of Pericytes and Basement‑Membrane Weakness
   Microscopic studies show a striking absence of pericytes—contractile cells that wrap around capillaries—in Coats vessels. Without this support, the vessel walls become paper‑thin and burst like weak balloons.

5. Inflammatory Cytokine Surge
   Analyses of eye fluid reveal high levels of inflammatory messengers such as interleukin‑6 and TNF‑alpha. These substances loosen vessel cell junctions, making the leakage worse and sustaining chronic swelling.

6. Gender‑Related Hormonal Influence
   The strong male predominance suggests androgens (male hormones) or X‑linked protective genes may play a role, although no definitive hormonal trigger has been found.

7. Early Childhood Viral or Bacterial Infections
   Some parents recall a severe febrile illness shortly before symptoms appeared. The theory is that infection‑induced immune activation could damage vulnerable retinal capillaries.

8. Head or Eye Trauma
   Blunt eye injury can temporarily raise VEGF and break down the blood‑retina barrier. In a susceptible eye this might accelerate dormant telangiectasias into full‑blown leakage.

9. Exposure to Ionizing Radiation
   Retinal endothelium is sensitive to radiation; prior treatment for brain tumors or other cancers has occasionally preceded Coats‑like changes.

10. High Blood Lipid Levels
    Children with very high LDL (“bad”) cholesterol—often due to familial hypercholesterolemia—can develop fatty exudates more quickly once leakage begins.

11. Premature Birth and Low Birth Weight
    Premature infants undergo rapid, irregular retinal vessel growth that can set the scene for later vascular instability, even if classic retinopathy of prematurity never occurred.

12. Systemic Vascular Disorders
    Diseases that weaken small blood vessels—such as Ehlers‑Danlos syndrome or collagen‑vascular disorders—may predispose the retina to telangiectasia.

13. Oxidative Stress from Smoking or Pollution
    Long‑term exposure to tobacco smoke or high‑pollution environments generates free radicals that weaken vascular walls throughout the body, including the eye.

14. Chronic Hypertension
    Elevated blood pressure thickens and narrows retinal arterioles, forcing delicate capillaries to dilate under back pressure and leak.

15. Nutritional Deficiencies (Vitamin A, Vitamin C, Omega‑3 Fats)
    These nutrients help maintain healthy endothelial cells. Deficiency impairs vessel repair mechanisms and could tip the balance toward leakage.

---

Symptoms

Remember: many children cannot describe vision loss clearly, so parents and teachers need to watch for subtle clues.

1. White or Yellow Pupil Reflection (Leukocoria)
   In flash photos the affected eye may shine white‑yellow instead of red. This occurs because fatty exudates reflect light back through the pupil.

2. Gradual Blurring or Distortion of Central Vision
   Swelling near the macula bends straight lines, making words or faces look wavy or blurry. Children might move closer to the television or cover one eye without realizing.

3. Peripheral (“Side‑Vision”) Shadows
   As exudates accumulate in the outer retina, dark curtains may creep inward from the edges, though youngsters rarely notice until severe.

4. Crossed or Out‑Turning Eye (Strabismus)
   The brain may ignore the blurry eye to avoid double vision, allowing its alignment muscles to drift. Parents often spot an eye turning inward or outward.

5. Eye Pain or Redness in Late Stages
   When a total retinal detachment raises eye pressure, the globe becomes inflamed and aching. Thankfully this is rare if disease is detected early.

6. Floaters or Flashes of Light
   Small clumps of blood or vitreous traction tugging on the retina create dark specks or flickers of light, warning of active leakage or traction.

7. Poor Night Vision
   The rod cells responsible for low‑light sight suffer from chronic edema and oxygen shortage, making dim rooms challenging.

8. Loss of Color Brilliance
   Swollen macular tissue dulls vibrant hues. Children may complain that colors look “washed out” or toys look “paler” in one eye.

9. Head‑Tilting or Face‑Turning
   To place the healthy part of the retina onto an object, the child may adopt an unusual chin‑up or sideways head posture that relieves blur.

10. Lagging at School or Sports
    Undiagnosed monocular vision loss can lower reading speed and hand‑eye coordination, showing up as academic or athletic struggles.

---

Diagnostic Tests

Doctors combine information from physical and manual examinations, laboratory and pathological tests, electrodiagnostic studies, and advanced imaging to separate Coats disease from mimicking conditions like retinoblastoma, retinal detachment of other causes, or diabetic retinopathy.

Physical‑Exam‑Based Tests

1. Visual‑Acuity Testing (Snellen or Lea Charts)
   Measures how clearly the patient can read letters or match symbols at a fixed distance. A drop in acuity alerts the doctor to macular involvement.

2. Pupillary Light Reflex (Swinging Flashlight Test)
   Comparing pupil constriction between eyes detects an afferent defect, suggesting significant retinal or optic‑nerve damage in the Coats eye.

3. Color‑Vision Assessment (Ishihara Plates)
   Color‑dot charts reveal early macular swelling when patients confuse red‑green patterns.

4. Confrontation Visual‑Field Screening
   The examiner wiggles fingers from the periphery toward the center; missing fingers indicates side‑vision loss from exudates or detachment.

Manual Ophthalmic Tests

5. Slit‑Lamp Biomicroscopy with +90 Diopter Lens
   Provides a magnified, three‑dimensional view of the retina. Telangiectatic vessels appear as bright red aneurysms amid yellow exudates.

6. Indirect Ophthalmoscopy under Dilated Pupil
   Using a head‑mounted light and concave lens, the specialist surveys the entire retinal periphery, mapping the full extent of leakage and staging the disease.

7. Intraocular Pressure Measurement (Applanation or Rebound Tonometry)
   Gauges eye pressure; prolonged retinal detachment can raise pressure, signaling impending pain and the need for surgical intervention.

8. Cover–Uncover Test for Strabismus
   Alternately covering each eye reveals hidden eye turns that may indicate significant visual impairment in the diseased eye.

Laboratory and Pathological Tests

9. Complete Blood Count (CBC)
   Rules out leukemia or severe anemia, which can produce Coats‑like retinal changes. An abnormal CBC prompts further systemic evaluation.

10. Fasting Lipid Profile
    Elevated LDL or triglycerides accelerate exudate formation; identifying dyslipidemia guides dietary or medical therapy to slow progression.

11. C‑Reactive Protein and Erythrocyte Sedimentation Rate
    These inflammatory markers help distinguish Coats disease (usually normal) from inflammatory vasculitides that mimic it.

12. ND Phx Gene Analysis (Targeted Next‑Generation Sequencing)
    Detects somatic or germline mutations in NDP or related genes, confirming an underlying molecular mechanism and counseling parents about recurrence risk.

Electrodiagnostic Tests

13. Full‑Field Electroretinogram (ERG)
    Measures electrical responses of rod and cone cells to light flashes. In Coats disease, rods are often reduced in the affected eye, correlating with night‑vision problems.

14. Pattern Visual‑Evoked Potential (VEP)
    Records brainwave responses to checkerboard patterns, quantifying optic‑nerve conduction and revealing hidden amblyopia (lazy eye).

15. Electro‑Oculogram (EOG)
    Evaluates retinal pigment epithelium (RPE) health by tracking eye‑movement‑related electrical shifts; a low Arden ratio flags widespread RPE stress from chronic exudation.

Imaging Tests

16. Color Fundus Photography
    Standard, high‑resolution pictures document baseline vessel abnormalities and exudates, allowing objective comparison over time.

17. Optical Coherence Tomography (OCT)
    A painless, light‑based scan builds a cross‑section “slice” of the retina, revealing minute cysts, sub‑retinal fluid, and thickness changes invisible to the naked eye.

18. Optical Coherence Tomography Angiography (OCTA)
    An advanced OCT mode maps blood flow without dye injection, highlighting telangiectasias and non‑perfused (dead) capillary zones that predict progression.

19. Fluorescein Fundus Angiography (FFA)
    After an intravenous fluorescent dye, rapid‑fire photos capture dye leaking from abnormal vessels. FFA pinpoints active hotspots for targeted laser therapy.

20. B‑Scan Ocular Ultrasonography
    Useful when dense exudates or vitreous haze block the doctor’s view. Sound waves depict total retinal detachment or hidden masses that might mimic Coats disease. (MRI or CT of the orbit may follow if a tumor is suspected.)

Non‑pharmacological treatments

1. Guided eye‑tracking drills – Using a Brock string or tablet apps, the child practises smooth pursuit and saccades for 10 minutes/day. Purpose: keeps extraocular muscles supple and improves fixation on the better‑seeing retina. Mechanism: repetitive focus–refocus recruits neuroplasticity to strengthen alternative retinal loci.

2. Saccadic reading therapy – Rapid left‑to‑right eye jumps on oversized text accelerate visual‑processing speed and reduce reading fatigue; improved saccades may reduce amblyopia risk.

3. Vestibulo‑ocular‑reflex (VOR) training – Holding a target card while gently nodding or turning the head helps the brain stabilise images despite micro‑nystagmus caused by retinal oedema.

4. Moderate‑intensity walking programme – 30 minutes brisk walking, 5 days/week, supports cardiovascular health; better systemic perfusion optimises retinal oxygen delivery and combats secondary ischemia.

5. Resistance‑band upper‑body workouts – Twice weekly sessions maintain muscle mass, improve insulin sensitivity, and reduce systemic inflammation that can worsen exudation.

6. Swimming or aquatic therapy – Buoyant, low‑impact exercise keeps heart rate up while protecting the eye from jolts; chlorinated goggles minimise infection risk.

7. Balance‑board exercises – Three 5‑minute sets daily sharpen proprioception and reduce fall risk in children with depth‑perception loss.

8. Pilates core‑strengthening – Strong core muscles aid posture during prolonged screen use (important for low‑vision e‑learning).

---

9. Mindfulness meditation – Ten conscious‑breathing minutes morning and night lower cortisol, which may indirectly temper VEGF expression and ease peri‑injection anxiety.

10. Hatha‑based yoga – Gentle poses (e.g., child’s pose, cat‑cow) boost blood flow without Valsalva strain; inverted poses are avoided to prevent increased ocular venous pressure.

11. Tai Chi – Slow, fluid movements improve balance and body awareness, shown in small trials to raise quality‑of‑life scores in low‑vision adults.

12. Progressive muscle relaxation – Bed‑time tension–release cycles ease sleep‑onset, crucial for growth‑hormone pulses that support retinal repair.

13. Guided imagery – Audio scripts help children picture healthy retinas sealing themselves, enhancing adherence to clinic visits.

14. Diaphragmatic breathing – 4‑7‑8 rhythm breathing during intravitreal injections curbs sympathetic spikes and perceived pain.

---

15. Low‑vision rehabilitation training – Certified specialists teach eccentric‑viewing techniques, magnifier use and contrast enhancement; empowers independence.

16. Orientation & mobility instruction – White‑cane skills and sighted‑guide techniques reduce collision injuries in kids with peripheral field loss.

17. Assistive‑technology coaching – Screen readers, high‑contrast modes and speech‑to‑text software keep academic performance on track.

18. Peer‑support groups – Sharing coping tips normalises the experience and reduces parental guilt.

19. Parent education workshops – Explains disease stages, treatment schedules and home monitoring, preventing missed appointments.

20. Symptom‑tracking diary or app – Logging flashes, floaters or colour changes prompts timely medical review.

---

Drugs used in Coats disease

(All intravitreal doses are per injection; frequency typically monthly until anatomy stabilises, then pro re nata)

1. Bevacizumab 1.25 mg/0.05 mL (anti‑VEGF, off‑label) – Shrinks leaking telangiectasia, dries sub‑retinal fluid. Side effects: transient IOP rise, rare tractional fibrosis. NCBIPMC

2. Ranibizumab 0.5 mg (anti‑VEGF) – Similar to bevacizumab but humanised Fab‑fragment; lower systemic exposure.

3. Aflibercept 2 mg (VEGF‑trap) – Binds VEGF‑A, VEGF‑B and PlGF; useful in recalcitrant macular oedema; extended dosing every 8 weeks. Wikipedia

4. Faricimab 6 mg (dual Ang‑2/VEGF‑A blocker) – Early case reports show faster exudate resolution with 12‑ to 16‑week intervals.

5. Brolucizumab 6 mg (single‑chain antibody fragment) – High molarity allows deep tissue penetration; watch for retinal vasculitis.

6. Triamcinolone acetonide 4 mg (intravitreal corticosteroid) – Potent anti‑oedema; given every 3–4 months. Risks: cataract, steroid‑induced glaucoma. PMC

7. Dexamethasone implant 0.7 mg (Ozurdex®) – Biodegradable rod releasing drug over 4–6 months; fewer office visits.

8. Verteporfin 6 mg/m² IV + 689 nm laser (photodynamic therapy) – Selectively closes telangiectatic channels; avoids widespread retinal burn.

9. Acetazolamide 250 mg orally, three times daily (carbonic‑anhydrase inhibitor) – Short‑term adjunct to lower cystoid macular oedema; tingling fingers and metabolic acidosis are dose‑limiting.

10. Prednisolone 1 mg/kg/day PO × 1–2 weeks – Used when exuberant inflammatory exudation flares after cryotherapy; taper to avoid adrenal suppression.

---

Dietary molecular supplements

(Daily adult doses; children receive weight‑adjusted equivalents after paediatric advice)

1. Omega‑3 DHA/EPA 1000 mg – Anti‑inflammatory eicosanoid shift, stabilises photoreceptor membranes.

2. Lutein 10 mg & Zeaxanthin 2 mg – Filter blue‑light, quench retinal free‑radicals, proven in AREDS‑2 to slow macular damage.

3. Vitamin C 500 mg – Ascorbate scavenges reactive oxygen species in the aqueous humour.

4. Vitamin E 400 IU – Fat‑soluble antioxidant protecting membrane lipids.

5. Zinc oxide 25 mg – Cofactor for retinal dehydrogenase; boosts antioxidant enzymes.

6. Beta‑carotene 5000 IU – Precursor of retinal; avoid in smokers owing to lung‑cancer risk.

7. Astaxanthin 4 mg – Crosses blood‑retinal barrier, dampens photoreceptor mitochondrial stress.

8. Curcumin 500 mg BID – Blocks NF‑κB; nano‑formulations improve bioavailability.

9. Resveratrol 150 mg – Activates SIRT‑1, linked to vascular stability in animal models.

10. Ginkgo biloba extract 120 mg – Improves ocular microcirculation; mild antiplatelet effect—pause before surgery.

---

Regenerative or stem‑cell‑based therapeutics

1. Autologous CD34⁺ bone‑marrow stem cells, 1 × 10⁶ cells intravitreal – Homing to ischemic retina, secreting angioprotective cytokines. Early phase 1 studies show safety and modest acuity gains. PentaVision

2. Umbilical‑cord mesenchymal stem cells, 1 × 10⁶ cells intravitreal – Release anti‑inflammatory exosomes; trials underway for diabetic macular oedema are being extrapolated to Coats‑related oedema.

3. hESC‑derived retinal‑pigment‑epithelium patch, 50 000 cells subretinal – Replaces damaged RPE, supports photoreceptors; immune suppression required.

4. iPSC‑retinal sheet transplant – Patient‑specific tissue reduces rejection risk while restoring outer‑nuclear‑layer architecture.

5. AAV‑sFLT‑1 gene therapy, 1 × 10¹¹ vg subretinal – Turns photoreceptors into anti‑VEGF factories, maintaining a steady intravitreal inhibitor level.

6. RGX‑314 (AAV8‑anti‑VEGF), 2.5 × 10¹¹ vg suprachoroidal – Phase 2 trials report > 70 % reduction in injection burden across retinal vascular disorders; mechanism: continuous secretion of anti‑VEGF antibody‑like protein.

---

Surgical / procedural options

1. Laser photocoagulation – Under local or GA, 200–500 µm burns are applied to leaking telangiectasia guided by wide‑field angiography. Benefits: seals vessels, preserves central vision in stage 2 disease. NCBI

2. Trans‑scleral cryotherapy – Double freeze‑thaw cycles over exudative retina when fluid thickness blocks laser; freezes and obliterates abnormal vessels.

3. Photodynamic therapy (PDT) – Verteporfin is given IV; 15 minutes later a cold 689 nm laser activates it locally, sparing healthy capillaries.

4. Pars plana vitrectomy with endolaser & gas/oil tamponade – Removes traction, drains subretinal fluid, permits internal laser; chosen for subtotal/total exudative detachments.

5. External drainage with scleral buckle – A drainage cannula releases subretinal fluid; silicone band supports retina while endolaser or cryo treats telangiectasia. Benefit: avoids enucleation in stage 4 eyes.

(Enucleation reserved for painful, blind stage 5 eyes.) NCBI

---

Prevention and early‑detection tips

1. Schedule infant eye screening by 6–12 months and yearly until age 6.

2. Photograph children’s eyes with flash; seek care for white‑pupil reflex.

3. Fit polycarbonate sports goggles during ball games.

4. Control blood pressure—adult‑onset Coats often coexists with hypertension.

5. Keep cholesterol and triglycerides in check; lipid spikes worsen exudation.

6. No smoking or vaping—nicotine accelerates retinal ischemia.

7. Eat colourful fruits & leafy greens rich in carotenoids.

8. Expecting mothers avoid alcohol, retinoic‑acid drugs and radiation.

9. Families with Norrie disease/FEVR get genetic counselling.

10. Even after successful treatment, maintain 6‑monthly retinal reviews for the fellow eye.

---

When should you see a doctor immediately?

• New floaters, flashes, or a curtain‑like shadow

• Sudden blurred or distorted vision

• Strabismus or eye turning inwards/outwards

• Eye redness plus severe pain or headache

• Any white or yellow glow in photographs

These may signal active leakage, detachment or secondary glaucoma needing urgent care. NCBI

---

Dos & don’ts at home

Do

1. Keep all injection and laser appointments.

2. Use prescribed eye‑drops exactly as directed.

3. Wear UV‑blocking sunglasses outdoors.

4. Maintain a balanced, antioxidant‑rich diet.

5. Keep a vision diary—note daily changes.

Don’t
6. Rub or press on the treated eye.
7. Skip protective eyewear during contact sports.
8. Smoke or stay in smoky rooms.
9. Ignore high blood pressure or diabetes.
10. Self‑medicate with over‑the‑counter steroids.

---

FAQs

1. Is Coats disease cancer? – No; it is vascular, but it can mimic retinoblastoma on exam.

2. Can it spread to the other eye? – Rarely (< 5 %). Regular checks catch subtle changes early.

3. Does it run in families? – True genetic inheritance is exceptionally rare; most cases are random.

4. Will glasses cure it? – Glasses correct refractive error but do not stop leakage.

5. How many laser sessions will I need? – Typically two to four, spaced 2–3 months apart.

6. Are anti‑VEGF injections painful? – Numbing drops and a lid speculum make them quick and nearly painless; slight scratchy feeling after is common.

7. Can diet alone fix Coats disease? – No, diet is supportive; structural vessel closure still requires medical/surgical therapy.

8. Is screen time harmful? – High‑contrast screens are fine; fatigue, not disease activity, causes most discomfort.

9. What are the long‑term prospects? – If caught in stage 1–2, > 80 % keep functional vision; late stages may need complex surgery.

10. Can adults suddenly get it? – Yes; hypertension‑linked adult‑onset cases occur, usually milder.

11. Does pregnancy worsen it? – Hormonal changes rarely flare leakage; obstetrician and ophthalmologist should co‑manage.

12. Why avoid heavy lifting? – Valsalva manoeuvres can spike eye venous pressure and promote fresh haemorrhage.

13. Is travel by air safe? – After gas tamponade, you must delay flights; otherwise, routine air travel is acceptable.

14. Will my child need a cane? – Only if peripheral detachment severely narrows the field; low‑vision rehab assesses this.

15. What new treatments are coming? – Gene therapy (RGX‑314), port‑delivery anti‑VEGF implants and stem‑cell patches are in mid‑phase trials with encouraging early results.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 17, 2025.